Nave R - Search Results

1

In vitro metabolism of ciclesonide in human nasal epithelial cells.

Sato H, Nave R, Nonaka T, Mochizuki T, Takahama S, Kondo S. Sato H, et al. Among authors: nave r. Biopharm Drug Dispos. 2007 Jan;28(1):43-50. doi: 10.1002/bdd.529. Biopharm Drug Dispos. 2007. PMID: 17117454

2

Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa.

Sato H, Nave R, Nonaka T, Yoshihisa N, Atsuhiro N, Mochizuki T, Takahama S, Kondo S, Wingertzahn M. Sato H, et al. Among authors: nave r. BMC Pharmacol. 2007 Jun 6;7:7. doi: 10.1186/1471-2210-7-7. BMC Pharmacol. 2007. PMID: 17553148 Free PMC article.

3

In Vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices.

Nave R, Fisher R, Zech K. Nave R, et al. Biopharm Drug Dispos. 2006 May;27(4):197-207. doi: 10.1002/bdd.500. Biopharm Drug Dispos. 2006. PMID: 16566061

4

Comparative in vitro metabolism of 14C-ciclesonide in hepatocytes from the mouse, rat, rabbit, dog, and human.

Gu Z, Zhao XG, Nave R, Liu DD, Feng H, Wu J, Howell SR, Guo Z. Gu Z, et al. Among authors: nave r. Am J Ther. 2007 May-Jun;14(3):280-90. doi: 10.1097/01.mjt.0000209691.75442.de. Am J Ther. 2007. PMID: 17515705

5

The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue.

Mutch E, Nave R, McCracken N, Zech K, Williams FM. Mutch E, et al. Among authors: nave r. Biochem Pharmacol. 2007 May 15;73(10):1657-64. doi: 10.1016/j.bcp.2007.01.031. Epub 2007 Jan 28. Biochem Pharmacol. 2007. PMID: 17331475

6

Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis.

Nave R, Wingertzahn MA, Brookman S, Kaida S, Matsunaga T. Nave R, et al. J Clin Pharmacol. 2006 Apr;46(4):461-7. doi: 10.1177/0091270006286437. J Clin Pharmacol. 2006. PMID: 16554455 Clinical Trial.

7

In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices.

Nave R, Fisher R, McCracken N. Nave R, et al. Respir Res. 2007 Sep 20;8(1):65. doi: 10.1186/1465-9921-8-65. Respir Res. 2007. PMID: 17883839 Free PMC article.

8

Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation.

Drollmann A, Nave R, Steinijans VW, Baumgärtner E, Bethke TD. Drollmann A, et al. Among authors: nave r. Clin Pharmacokinet. 2006;45(7):729-36. doi: 10.2165/00003088-200645070-00007. Clin Pharmacokinet. 2006. PMID: 16802853 Clinical Trial.

9

An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis.

Ratner P, Wingertzahn MA, Herzog R, Huang H, Desai SY, Maier G, Nave R. Ratner P, et al. Among authors: nave r. Pulm Pharmacol Ther. 2011 Aug;24(4):426-33. doi: 10.1016/j.pupt.2011.04.002. Epub 2011 Apr 8. Pulm Pharmacol Ther. 2011. PMID: 21501692 Clinical Trial.

10

Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.

Nave R, Bethke TD, van Marle SP, Zech K. Nave R, et al. Clin Pharmacokinet. 2004;43(7):479-86. doi: 10.2165/00003088-200443070-00004. Clin Pharmacokinet. 2004. PMID: 15139796 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page